Navigating ISO 10993-1:2025 in Practice: What’s Changed and What Regulators Expect Now

GMED Expert Shahriar Sharifi to Share Insights on ISO 10993-1:2025 and Evolving Biocompatibility Expectations

Shahriar Sharifi, PhD, GMED expert in medical device biological evaluation, will join ELIQUENT Life Sciences for an upcoming webinar on September 29, 2026, exploring the practical implications of ISO 10993-1:2025.

The session, “Navigating ISO 10993-1:2025 in Practice: What’s Changed and What Regulators Expect Now,” will examine new requirements, biocompatibility challenges under the EU MDR, common assessment considerations, and key factors when selecting a testing laboratory. The discussion will provide manufacturers with practical insights to strengthen their biological evaluation strategy and anticipate potential challenges during regulatory assessment.

Register Here